Holen Sie sich die Stockscreener-App
46.94
2.71%
1.25
Handel nachbörslich:
46.92
-0.02
-0.04%
Schlusskurs vom Vortag:
$45.69
Offen:
$46.01
24-Stunden-Volumen:
1.77M
Relative Volume:
0.83
Marktkapitalisierung:
$7.15B
Einnahmen:
$3.46B
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-195.26
EPS:
-0.2404
Netto-Cashflow:
$51.30M
1W Leistung:
+10.19%
1M Leistung:
+28.40%
6M Leistung:
-4.28%
1J Leistung:
+32.20%
1-Tages-Spanne:
$44.95
$47.30
1-Wochen-Bereich:
$41.62
$47.30
52-Wochen-Spanne:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
46.94 | 6.96B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker (BRKR) Unveils Advanced BioSpec 18T MRI System in Lisbon - GuruFocus
MA-BRUKER-CORP - The Facts
Inside the world’s highest-field MRI now probing cancer and the brain in Lisbon - Stock Titan
Bruker Corporation (BRKR) Stock Analysis: Exploring a 7.58% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corporation 8-K SEC Filing Summary – Company Information, Address, and Securities Details (May 21, 2026) - Minichart
Bruker stockholders elect directors and approve proposals at annual meeting - Investing.com
Bruker (NASDAQ: BRKR) investors back board slate and auditor at 2026 meeting - Stock Titan
Bruker Corp Annual Shareholders Meeting Transcript - GuruFocus
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
A Look at Bruker Corp (BRKR) After 3.9% Gain -- GF Value $62.37 vs Price $44.27 - GuruFocus
Thrivent Financial for Lutherans Acquires 152,603 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker (BRKR) director receives 2,886 RSUs vesting in 2027 - Stock Titan
Bruker (NASDAQ: BRKR) EVP exercises options and sells 2,000 shares under plan - Stock Titan
Bruker Corp stock (US1167941087): upbeat guidance and life-science demand support growth story - AD HOC NEWS
[8-K] BRUKER CORP Reports Material Event - Stock Titan
2,000-share proposed sale via option exercise (BRKR) reported - Stock Titan
Orbis group discloses 11.8% stake in Bruker Corp (BRKR) - Stock Titan
Bruker (NASDAQ:BRKR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Assessing Whether Bruker (BRKR) Looks Undervalued After Recent Share Price Momentum - Yahoo Finance
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Wall Street Zen Upgrades Bruker (NASDAQ:BRKR) to Buy - MarketBeat
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - Moomoo
Bruker Corp. Opens with a 10.16% Gain, Outperforming S&P 500's 1.46% Rise - Markets Mojo
Bruker Corporation (NASDAQ:BRKR) Q1 2026 Earnings Call Transcript - Insider Monkey
Bruker Corp. Hits Day High with 11.29% Surge in Stock Price - Markets Mojo
Bruker Price Target Raised to $45.00/Share From $43.00 by TD Cowen - Moomoo
UBS Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - 富途牛牛
Bruker Is Maintained at Hold by TD Cowen - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Bruker (NASDAQ: BRKR) Q1 2026 revenue reaches $823M amid restructuring - Stock Titan
UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating - Moomoo
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53 - 富途牛牛
UBS Group AG Lowers Stock Holdings in Bruker Corporation $BRKR - MarketBeat
BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down - Yahoo Finance
BRUKER ($BRKR) Releases Q1 2026 Earnings - Moomoo
TD Cowen Initiates Bruker Corp(BRKR.US) With Hold Rating, Announces Target Price $45 - 富途牛牛
How many employees work at Bruker Optics? - Revelio Labs
BRUKER CORPORATION (BRKR) - MSN
Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook - Moomoo
Bruker Q1 2026 slides: beats estimates despite organic revenue decline - Investing.com
FMR LLC boosts stake in Bruker (NASDAQ: BRKR) to 12.4% - Stock Titan
Bruker Q1 Earnings Call Highlights - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings - MarketBeat
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises - Investing.com
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026Bruker Corp., Cubresa, and Siemens Healthineers Lead - Yahoo Finance UK
Full Transcript: Bruker Q1 2026 Earnings CallBruker (NASDAQ:BRKR) - Benzinga
Q1 2026 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker (NASDAQ:BRKR) Beats Q1 Estimates but Maintains Cautious Full-Year Guidance Amid Organic Revenue Decline - ChartMill
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
May 15 '26 |
Sale |
43.90 |
2,000 |
87,800 |
128,443 |
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):